Literature DB >> 22057978

Inhibition of sodium current by taurine magnesium coordination compound prevents cesium chloride-induced arrhythmias.

Yongqiang Yin1, Ke Wen, Yanna Wu, Yi Kang, Jianshi Lou.   

Abstract

The mechanism(s) by which taurine magnesium coordination compound (TMCC) inhibits experimental arrhythmias remains poorly understood. The purpose of this study was to observe the effects of TMCC against cesium chloride-induced arrhythmia in the rabbit heart and find whether the antiarrhythmic activity is related to inhibition of sodium current. Early afterdepolarization was induced by 1.5 mM cesium chloride (1 ml kg(-1)) through intravenous injection. The monophasic action potentials (MAP) and electrocardiograms were simultaneously recorded. The effect of TMCC on functional refractory periods (FRPs) in the left atrium was also observed in vitro. Arrhythmias onset was significantly retarded by TMCC. The number of ventricular premature contractions and incidence of monophasic ventricular tachycardia and polyphasic ventricular tachycardia in 10 min were decreased by TMCC. These effects can be abolished by veratridine (10 μg kg(-1)). MAP duration at 90% repolarization was significantly prolonged by TMCC, which can be prolonged even longer by veratridine (10 μg kg(-1)). In vitro experiments showed that FRPs was prolonged by TMCC which can be cancelled by veratridine (10 μg kg(-1)). TMCC prevents cesium chloride-induced arrhythmias, and inhibition of sodium current, in part, contributes to the antiarrhythmic effect of TMCC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22057978     DOI: 10.1007/s12011-011-9240-5

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  5 in total

Review 1.  Role of taurine, its haloamines and its lncRNA TUG1 in both inflammation and cancer progression. On the road to therapeutics? (Review).

Authors:  Stella Baliou; Anthony M Kyriakopoulos; Demetrios A Spandidos; Vassilios Zoumpourlis
Journal:  Int J Oncol       Date:  2020-07-14       Impact factor: 5.650

2.  Therapeutic effects of a taurine-magnesium coordination compound on experimental models of type 2 short QT syndrome.

Authors:  Meng-Yao An; Kai Sun; Yan Li; Ying-Ying Pan; Yong-Qiang Yin; Yi Kang; Tao Sun; Hong Wu; Wei-Zhen Gao; Jian-Shi Lou
Journal:  Acta Pharmacol Sin       Date:  2017-10-26       Impact factor: 6.150

3.  Taurine Attenuates the Hypotaurine-Induced Progression of CRC via ERK/RSK Signaling.

Authors:  Xiaodan Hou; Junwei Hu; Xinyu Zhao; Qing Wei; Rongping Zhao; Min Li; Qiong Li
Journal:  Front Cell Dev Biol       Date:  2021-04-15

4.  Circulating Glutamate and Taurine Levels Are Associated with the Generation of Reactive Oxygen Species in Paroxysmal Atrial Fibrillation.

Authors:  Shintaro Takano; Kousuke Fujibayashi; Nakaba Fujioka; Ei-ichi Ueno; Minoru Wakasa; Yasuyuki Kawai; Kouji Kajinami
Journal:  Dis Markers       Date:  2016-01-06       Impact factor: 3.434

5.  Effect of taurine on cell proliferation and apoptosis human lung cancer A549 cells.

Authors:  Shuo Tu; Xia-Li Zhang; Hui-Fang Wan; Yan-Qin Xia; Zhuo-Qi Liu; Xiao-Hong Yang; Fu-Sheng Wan
Journal:  Oncol Lett       Date:  2018-02-13       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.